Evidence map›Paper›PMID 38192973›Full record

ArticleTranslational cancer research2023

Initial experience in robot-associated radical nephrectomy with inferior vena cava tumor thrombectomy.

Kojiro Ohba, Kensuke Mitsunari, Hiromi Nakanishi, Takuji Yasuda, Yuichiro Nakamura, Tomohiro Matsuo, Yasushi Mochizuki, Ryoichi Imamura

Open access · diamondAbstract read
In one paragraph

Article in Translational cancer research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Kojiro OhbaDepartment of Urology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Kensuke MitsunariDepartment of Urology and Renal Transplantation, Nagasaki University Hospital, Nagasaki, Japan.
Hiromi NakanishiDepartment of Urology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Takuji YasudaDepartment of Urology and Renal Transplantation, Nagasaki University Hospital, Nagasaki, Japan.
Yuichiro NakamuraDepartment of Urology and Renal Transplantation, Nagasaki University Hospital, Nagasaki, Japan.
Tomohiro MatsuoDepartment of Urology and Renal Transplantation, Nagasaki University Hospital, Nagasaki, Japan.
Yasushi MochizukiDepartment of Urology and Renal Transplantation, Nagasaki University Hospital, Nagasaki, Japan.
Ryoichi ImamuraDepartment of Urology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Nagasaki University Hospital · JPNagasaki University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Renal cell carcinoma (RCC) is often locally invasive and may extend from the renal vein into the inferior vena cava (IVC) as a venous tumor thrombus (VTT). Radical nephrectomy with IVC tumor thrombectomy (IVC-TT) via an open approach has been shown to carry high morbidity and mortality. Recently, robot-associated radical nephrectomy (RARN) has been developed with the aim of improving the performance and outcomes of surgery for RCC with IVC-VTT. Methods: We here present four patients who had right RCC with IVC-VTT and underwent RARN with IVC-TT in Nagasaki University Hospital. All four patients had level II IVC-TT and underwent RARN with IVC-TT using a da Vinci Xi surgical system. The procedure comprised performing the Kocher maneuver, exposing the right renal artery in the aortocaval region dorsal to the left renal vein, exposing, mobilizing, and clipping the IVC, clamping and incising the IVC, and removing the kidney with the VTT Results: The mean tumor size was 83.1 (range, 50.1-115.2) mm and the mean length of the VTT within the IVC 41.6 (range, 25.3-44.3) mm. The mean console time was 290 (range, 287-367) minutes and the mean blood loss was 200 (range, 175-260) mL and no patient required blood transfusion. Conclusions: Our initial experience of the procedure of RARN with IVC-TT for level II IVC-VTT is that it is safe and has acceptable perioperative outcomes and complications.

Indexed as

inferior vena cava tumor thrombectomy (IVC-TT)Renal cell carcinoma (RCC)robot-associated radical nephrectomy (RARN)venous tumor thrombus (VTT)

Identifiers

PMID38192973
PMCPMC10774025
OpenAlexW4390372955

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.